5:56 PM
 | 
Nov 27, 2012
 |  BC Extra  |  Company News

Lanthio partners with MorphoSys to develop lantipeptide library

Lanthio Pharma B.V. (Groningen, the Netherlands) partnered with MorphoSys AG (Xetra:MOR; Pink:MPSYF) to co-develop Lanthio Pharma's LanthioPep technology to create lantipeptide-based libraries. LanthioPep uses the Lactococcus lactis bacterium to generate lantipeptides,...

Read the full 148 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >